Skip to main content
Fig. 2 | BMC Neurology

Fig. 2

From: Integrative analysis of purine metabolites and gut microbiota in patients with neuromyelitis optica spectrum disorders after mycophenolate mofetil treatment

Fig. 2

Altered gut microbiota in NMOSD patients by their responses to MMF therapy. (A) Observed OTUs. (B) Chao1 index. (C) Shannon index. (D) Simpson index of the gut microbiota in EG and LEG samples. (E) Principal component analysis. (F) Composition of the gut microbiota at the genus levels in fecal samples in EG and LEG samples. (G) LEfSe (Linear discriminant analysis effect size) analysis showing taxa associated with therapeutic response of MMF. n = 23 for effective group (EG) and n = 11 for less-effective group (LEG). *p < 0.05

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us